1201844-77-0 Usage
Uses
Used in Pharmaceutical Research:
6-Bromo-3-methoxyquinoline is used as a key intermediate in the synthesis of various pharmaceutical compounds due to its unique structural features and biological activities. Its presence in the development of new drugs is attributed to its potential to modulate biological pathways relevant to disease treatment.
Used in Medicinal Chemistry:
6-Bromo-3-methoxyquinoline is utilized as a therapeutic agent for its anti-inflammatory and anti-cancer properties, making it a candidate for the treatment of various diseases, particularly those involving inflammation and cancer.
Used in Organic Synthesis:
As a building block, 6-Bromo-3-methoxyquinoline is used in the creation of a variety of biologically active compounds, contributing to the advancement of organic chemistry and the discovery of new molecules with potential applications in medicine and other fields.
Used in Biochemical and Cell Imaging Studies:
6-Bromo-3-methoxyquinoline is employed as a fluorescent dye in biochemical assays and cell imaging, allowing for the visualization and tracking of cellular processes and molecular interactions, which is crucial for understanding biological mechanisms and disease pathways.
Used in the Development of Drug Delivery Systems:
6-BroMo-3-Methoxyquinoline may also be integrated into drug delivery systems to enhance the efficacy and targeted delivery of therapeutic agents, improving treatment outcomes and reducing side effects in various medical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1201844-77-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,1,8,4 and 4 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1201844-77:
(9*1)+(8*2)+(7*0)+(6*1)+(5*8)+(4*4)+(3*4)+(2*7)+(1*7)=120
120 % 10 = 0
So 1201844-77-0 is a valid CAS Registry Number.
1201844-77-0Relevant academic research and scientific papers
INHIBITORS OF PI3 KINASE
-
Page/Page column 75, (2010/01/12)
The present invention relates to compounds of Formula (I), or a pharmaceutically acceptable salt thereof; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds, wherein Q, X1, X2, R1 and Z are as defined herein.
